| Application no. and date | 15184904.9 (espacenet) (Federated) (European Patent Register), 20100608 | | Patent/reg. no. and date | DK/EP 2982366, 20170913 | | Publication date | 20160210 | | Priority no. and date | US 185130 P, 20090608 | | EP pub. no. and date |
EP 2982366 20160210 | | Effective date | | | Applicant/owner | AbbVie Deutschland GmbH & Co. KG, Mainzer Strasse 81
65189 Wiesbaden, DE | | Applicant ref. no. | P016941EPDK2 EJ/Ve | | Inventor | KNOBLOCH, Martin, Medenheimerstrasse 22a
67141 Neuhofen, DE,
LIEPOLD, Bernd, Birkenweg 44
69221 Dossenheim, DE,
STEIGER, Norbert, Druslacherstrasse 1
67360 Lingenfeld, DE,
PACKHAEUSER, Claudia, Burgstrasse 7
68165 Mannheim, DE,
KOSTELAC, Drazen, R4
15
68161 Mannheim, DE | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 31/635 (2006.01) , A61K 47/22 (2006.01) , A61K 9/00 (2006.01) , A61K 9/14 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutisk doseringsform til oral administration af en hæmmer af BCL-2-familien | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
